Effect of the selective 5-HT₂ antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjectsCAZZOLA, M; MATERA, M. G; SANTANGELO, G et al.Immunopharmacology (New York). 1992, Vol 23, Num 1, pp 21-28, issn 0162-3109Article

Ketanserin alone and in combination with enalapril in the treatment of essential hypertension : assessment of the haemodynamic effectsDE DIVITIIS, O; GALDERISI, M; CELENTANO, A et al.Journal of international medical research. 1993, Vol 21, Num 3, pp 113-125, issn 0300-0605Article

Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patientsDE LORENZO, A; CECCANTI, M; ASSOGNA, G et al.International journal of clinical pharmacology research. 1988, Vol 8, Num 5, pp 321-325, issn 0251-1649Article

The antihypertensive effect of ketanserin versus captopril determined by harmonic fittingGERMANO, G; DAMIANI, S; PECCHIOLI, V et al.Current therapeutic research. 1991, Vol 49, Num 1, pp 65-73, issn 0011-393X, 9 p.Article

Ketanserin (S₂-receptor blocking agents), hypertension and chronic alcoholismDE LORENZO, A; CECCANTI, M; ROMEO, M et al.International journal of clinical pharmacology research. 1986, Vol 6, Num 1, pp 77-79, issn 0251-1649Article

Effect of ketanserin, a new blocking agent of the 5-HT₂ receptor, on airway responsiveness in asthmaCAZZOLA, M; ASSOGNA, G; LUCCHETTI, G et al.Allergy (Copenhagen). 1990, Vol 45, Num 2, pp 151-153, issn 0105-4538Article

Ketanserin and captopril interaction in the treatment of essential hypertensivesLAVEZZARO, G; LADETTO, P. E; VALENTE, M et al.Cardiovascular drugs and therapy. 1990, Vol 4, pp 119-122, issn 0920-3206, SUP1Conference Paper

Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbitFAVALLI, L; LANZA, E; ROZZA DIONIGI, A et al.Drugs under experimental and clinical research. 1985, Vol 11, Num 12, pp 845-850, issn 0378-6501Article

Acute respiratory and cardiovascular effects on inhaled ketanserin in chronic obstructive pulmonary disease : a comparative study with intravenously administered ketanserinCAZZOLA, M; GUIDETTI, E; SEPE, J et al.Chest. 1990, Vol 97, Num 4, pp 901-905, issn 0012-3692Article

Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertensionMALATINO, L. S; STANCANELLI, B; GRECO, G et al.Cardiovascular drugs and therapy. 1990, Vol 4, pp 123-126, issn 0920-3206, SUP1Conference Paper

Ketanserin, a new blocking agent of serotonin S₂-receptors: respiratory functional effects in chronic obstruction of the airwaysCAZZOLA, M; D'AMATO, G; LOBEFALO, G et al.Chest. 1987, Vol 92, Num 5, pp 863-866, issn 0012-3692Article

Platelet activation indices in short-term ketanserin treatmentCATALANO, M; RUSSO, U; BELLETTI, S et al.Journal of cardiovascular pharmacology. 1987, Vol 10, Num 3, pp 369-370, issn 0160-2446Article